468 related articles for article (PubMed ID: 27039996)
21. Myositis-related interstitial lung disease and antisynthetase syndrome.
Solomon J; Swigris JJ; Brown KK
J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438
[TBL] [Abstract][Full Text] [Related]
22. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
Plastiras SC; Soliotis FC; Vlachoyiannopoulos P; Tzelepis GE
Clin Rheumatol; 2007 Jan; 26(1):108-11. PubMed ID: 16328094
[TBL] [Abstract][Full Text] [Related]
23. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA;
Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
25. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
26. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
28. Antisynthetase syndrome: not just an inflammatory myopathy.
Chatterjee S; Prayson R; Farver C
Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
[TBL] [Abstract][Full Text] [Related]
30. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome.
Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R
ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592
[TBL] [Abstract][Full Text] [Related]
31. [The anti-synthetase syndrome].
Bergoin C; Bure M; Tavernier JY; Lamblin C; Maurage CA; Remy-Jardin M; Wallaert B
Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
[TBL] [Abstract][Full Text] [Related]
32. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
Labirua-Iturburu A; Selva-O'Callaghan A; Vincze M; Dankó K; Vencovsky J; Fisher B; Charles P; Dastmalchi M; Lundberg IE
Medicine (Baltimore); 2012 Jul; 91(4):206-211. PubMed ID: 22732951
[TBL] [Abstract][Full Text] [Related]
33. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).
Mejía M; Herrera-Bringas D; Pérez-Román DI; Rivero H; Mateos-Toledo H; Castorena-García P; Figueroa JE; Rojas-Serrano J
Respir Med; 2017 Feb; 123():79-86. PubMed ID: 28137500
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
[TBL] [Abstract][Full Text] [Related]
35. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
Mielnik P; Wiesik-Szewczyk E; Olesinska M; Chwalinska-Sadowska H; Zabek J
Autoimmunity; 2006 May; 39(3):243-7. PubMed ID: 16769658
[TBL] [Abstract][Full Text] [Related]
37. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
[TBL] [Abstract][Full Text] [Related]
38. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
Chong WH; Saha BK; Beegle S
Am J Med Sci; 2021 Apr; 361(4):526-533. PubMed ID: 33386120
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
Trallero-Araguás E; Grau-Junyent JM; Labirua-Iturburu A; García-Hernández FJ; Monteagudo-Jiménez M; Fraile-Rodriguez G; Les-Bujanda I; Rodriguez-Carballeira M; Sáez-Comet L; Selva-O'Callaghan A;
Semin Arthritis Rheum; 2016 Oct; 46(2):225-231. PubMed ID: 27139168
[TBL] [Abstract][Full Text] [Related]
40. Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
Marie I; Hatron PY; Cherin P; Hachulla E; Diot E; Vittecoq O; Menard JF; Jouen F; Dominique S
Arthritis Res Ther; 2013 Oct; 15(5):R149. PubMed ID: 24286268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
